![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 28, 25519-25526, July 12, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Departments of Cell Biology and Medicine, Division of
Gastroenterology, Duke University Medical Center,
Durham, North Carolina 27710
The vasoactive intestinal polypeptide
type-1 (VPAC1) receptor is a class II G
protein-coupled receptor, distinct from the adrenergic receptor
superfamily. The mechanisms involved in the regulation of the
VPAC1 receptor are largely unknown. We examined agonist-dependent VPAC1 receptor signaling,
phosphorylation, desensitization, and sequestration in human embryonic
kidney 293 cells. Agonist stimulation of cells overexpressing this
receptor led to a dose-dependent increase in cAMP that
peaked within 5-10 min and was completely desensitized after 20 min.
Cells cotransfected with the VPAC1 receptor
(VPAC1R) and G protein-coupled receptor kinases (GRKs) 2, 3, 5, and 6 exhibited enhanced desensitization that was not evident
with GRK 4. Immunoprecipitation of the epitope-tagged VPAC1
receptor revealed dose-dependent phosphorylation that was increased with cotransfection of any GRK. Agonist-stimulated
internalization of the VPAC1R peaked in 10 min, and neither
overexpressed
-arrestin nor its dominant-negative mutant altered
internalization. However, a dynamin-dominant negative mutant did
inhibit VPAC1 receptor internalization. Interestingly,
VPAC1R specificity in desensitization was not evident by
study of the overexpressed receptor; however, we determined that human
embryonic kidney 293 cells express an endogenous VPAC1R
that did demonstrate dose-dependent GRK specificity. Therefore, VPAC1 receptor regulation involves
agonist-stimulated, GRK-mediated phosphorylation,
-arrestin
translocation, and dynamin-dependent receptor
internalization. Moreover, study of endogenously expressed receptors
may provide information not evident in overexpressed systems.
To whom correspondence should be addressed: Duke University
Medical Center, Box 3083, Durham, NC 27710. Tel.: 919-681-6814; Fax: 919-684-4983; E-mail: shetz001@mc.duke.edu.
§
Recipient of an Medical Research Council/Canadian Lung
Association postdoctoral fellowship.
¶
Present address: Purdue Pharma, L.P., Cranbury, NJ 08512.
This article has been cited by other articles:
![]() |
R. Jorgensen, N. D. Holliday, J. L. Hansen, M. Vrecl, A. Heding, T. W. Schwartz, and C. E. Elling Characterization of G-Protein Coupled Receptor Kinase Interaction with the Neurokinin-1 Receptor Using Bioluminescence Resonance Energy Transfer Mol. Pharmacol., February 1, 2008; 73(2): 349 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Murthy, S. Mahavadi, J. Huang, H. Zhou, and W. Sriwai Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle Am J Physiol Cell Physiol, February 1, 2008; 294(2): C477 - C487. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Hamdan, M. D. Rochdi, B. Breton, D. Fessart, D. E. Michaud, P. G. Charest, S. A. Laporte, and M. Bouvier Unraveling G Protein-coupled Receptor Endocytosis Pathways Using Real-time Monitoring of Agonist-promoted Interaction between beta-Arrestins and AP-2 J. Biol. Chem., October 5, 2007; 282(40): 29089 - 29100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, S. Mahavadi, W. Sriwai, J. R. Grider, and K. S. Murthy Cross-regulation of VPAC2 receptor desensitization by M3 receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2 Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G867 - G874. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Langlet, I. Langer, P. Vertongen, N. Gaspard, J.-M. Vanderwinden, and P. Robberecht Contribution of the Carboxyl Terminus of the VPAC1 Receptor to Agonist-induced Receptor Phosphorylation, Internalization, and Recycling J. Biol. Chem., July 29, 2005; 280(30): 28034 - 28043. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jorgensen, L. Martini, T. W. Schwartz, and C. E. Elling Characterization of Glucagon-Like Peptide-1 Receptor {beta}-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype Mol. Endocrinol., March 1, 2005; 19(3): 812 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wiejak, L. Surmacz, and E. Wyroba Dynamin-association with agonist-mediated sequestration of beta-adrenergic receptor in single-cell eukaryote Paramecium J. Exp. Biol., April 15, 2004; 207(10): 1625 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. L. Walker, R. R. Gainetdinov, D. S. Feldman, P. K. McFawn, M. G. Caron, R. J. Lefkowitz, R. T. Premont, and J. T. Fisher G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L312 - L319. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Marie, C. Rouyer-Fessard, A. Couvineau, P. Nicole, H. Devaud, J. E. Benna, and M. Laburthe Serine 447 in the Carboxyl Tail of Human VPAC1 Receptor Is Crucial for Agonist-Induced Desensitization but Not Internalization of the Receptor Mol. Pharmacol., December 1, 2003; 64(6): 1565 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Willets, R. Mistry, S. R. Nahorski, and R. A. J. Challiss Specificity of G Protein-Coupled Receptor Kinase 6-Mediated Phosphorylation and Regulation of Single-Cell M3 Muscarinic Acetylcholine Receptor Signaling Mol. Pharmacol., November 1, 2003; 64(5): 1059 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kohout and R. J. Lefkowitz Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization Mol. Pharmacol., January 1, 2003; 63(1): 9 - 18. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |